Publications

'I don't think anybody explained to me how it works': qualitative study exploring vaccination and primary health service access and uptake amongst Polish and Romanian communities in England.

BELL, S; Edelstein, M; Zatoński, M; Ramsay, M; MOUNIER-JACK, S;

2019

BMJ open, (2019).9 7 10.1136/bmjopen-2018-028228.

Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.

Von Mollendorf, C; Dunne, EM; La Vincente, S; Ulziibayar, M; Suuri, B; Luvsantseren, D; Narangerel, D; Ortika, BD; Pell, CL; Nation, ML; Alamrousi, A; Hinds, J; Demberelsuren, S; Nguyen, C; Mungun, T; MULHOLLAND, EK; Satzke, C;

2019

VACCINE, (2019).37 30 10.1016/j.vaccine.2019.05.078.

Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.

WAGSTAFFE, HR; PICKERING, H; HOUGHTON, J; MOONEY, JP; WOLF, A-S; Prevatt, N; BEHRENS, RH; HOLLAND, MJ; RILEY, EM; GOODIER, MR;

2019

Journal of immunology, (2019).203 6 10.4049/jimmunol.1801648.

SAFETY AND IMMUNOGENICITY OF A 2-DOSE HETEROLOGOUS VACCINE AGAINST EBOLA IN AFRICAN CHILDREN AND ADOLESCENTS.

AFOLABI, M; Mutua, G; ANYWAINE, Z; Kibuuka, H; ISHOLA, D; Leigh, B; BAIDEN, F; Owusu-Kyei, K; Anzala, O; Samai, M; Blehou, J; GREENWOOD, B; MANNO, D; Bockstal, V; Gaddah, A; Heerwegh, D; Shukarev, G; Keshinro, B; Luhn, K; Leyssen, M; Robinson, C; Jones, D-W; Thiebaut, R; Douoguih, M; Barry, H;

2019

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2019).101,

Cytomegalovirus Antibody Responses Associated With Increased Risk of Tuberculosis Disease in Ugandan Adults.

STOCKDALE, L; NASH, S; FARMER, R; RAYNES, J; Mallikaarjun, S; NEWTON, R; FLETCHER, HA;

2019

The Journal of infectious diseases, (2019).221 7 10.1093/infdis/jiz581.

Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.

ODUTOLA, A; Ota, MO C; ANTONIO, M; Ogundare, EO; Saidu, Y; Owiafe, PK; Worwui, A; Idoko, OT; Owolabi, O; KAMPMANN, B; GREENWOOD, BM; Alderson, M; Traskine, M; Swinnen, K; Verlant, V; Dobbelaere, K; Borys, D;

2019

Vaccine, (2019).37 19 10.1016/j.vaccine.2019.03.033.

The global impact and cost-effectiveness of a melioidosis vaccine.

Luangasanatip, N; FLASCHE, S; DANCE, DA B; Limmathurotsakul, D; Currie, BJ; Mukhopadhyay, C; Atkins, T; Titball, R; JIT, M;

2019

BMC Medicine, (2019).17 1 10.1186/s12916-019-1358-x.

Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees-Timor Leste, 2016.

Li, AJ; Peiris, TS R; SANDERSON, C; Nic Lochlainn, L; Mausiry, M; Da Silva, RB J B M; Ogbuanu, IU;

2019

Vaccine, (2019).37 31 10.1016/j.vaccine.2019.06.041.

Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.

Sturkenboom, M; Bahri, P; Chiucchiuini, A; Grove Krause, T; Hahné, S; Khromava, A; Kokki, M; Kramarz, P; Kurz, X; LARSON, HJ; De Lusignan, S; Mahy, P; Torcel-Pagnon, L; Titievsky, L; Bauchau, V; ADVANCE consortium,;

2019

Vaccine, (2019).38 Sup, 10.1016/j.vaccine.2019.07.081.

Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.

Temple, B; Toan, NT; Dai, VT T; Bright, K; Licciardi, PV; Marimla, RA; Nguyen, CD; Uyen, DY; Balloch, A; Huu, TN; MULHOLLAND, EK;

2019

LANCET INFECTIOUS DISEASES, (2019).19 5 10.1016/S1473-3099(18)30734-5.